[go: up one dir, main page]

PE20030187A1 - Derivados de acido cicloalquilpirrol-3-carboxilico y derivados de acido heterocicloalquilpirrol-3-carboxilico - Google Patents

Derivados de acido cicloalquilpirrol-3-carboxilico y derivados de acido heterocicloalquilpirrol-3-carboxilico

Info

Publication number
PE20030187A1
PE20030187A1 PE2002000597A PE2002000597A PE20030187A1 PE 20030187 A1 PE20030187 A1 PE 20030187A1 PE 2002000597 A PE2002000597 A PE 2002000597A PE 2002000597 A PE2002000597 A PE 2002000597A PE 20030187 A1 PE20030187 A1 PE 20030187A1
Authority
PE
Peru
Prior art keywords
alkyl
derivatives
carboxyl acid
oxo
cyane
Prior art date
Application number
PE2002000597A
Other languages
English (en)
Inventor
Xiaojun Liu
Daniel Yohannes
George Daniel Maynard
Original Assignee
Pfizer Prod Inc
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc, Neurogen Corp filed Critical Pfizer Prod Inc
Publication of PE20030187A1 publication Critical patent/PE20030187A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

SE REFIERE A DERIVADOS DE ACIDO CICLOALQUILPIRROL O HETEROCICLOALQUILPIRROL-3-CARBOXILICO Y DERIVADOS DE FORMULA I DONDE R ES HALOGENO, CIANO, NITRO, AMINO; R1 ES AMINO, FLUORO, HIDROXI, ALCOXI C1-C6, ENTRE OTROS; R2 ES H, FLUORO, ALQUILO C1-C6, ARIL(ALQUILO C1-C4); R1 Y R2 JUNTOS SON OXO; R1 Y R2 FORMAN UN ANILLO DE 4-8 MIEMBROS CON N, S, O; n ES 0-2; A ES O, NR3, CR3´R3"; B ES O, NR4, CR4'R4"; C ES O, NR5, CR5'R5"; D ES O, NR6, CR6'R6"; R3, R4, R5, R6 SON H, ALQUILO C1-C6, ALQUENILO C2-C6, ENTRE OTROS; R3', R3", R4', R4", R5',R5", R6', R6" SON H, HALOGENO, HIDROXI, AMINO, CIANO, NITRO, OXO, ENTRE OTROS; CON LA CONDICION DE QUE AL MENOS UNO DE B, C, D ES N SUSTITUIDO CON CICLOALQUILO C3-C7, ENTRE OTROS; UNO DE B, C, D ES CARBONO SUSTITUIDO CON HALOGENO, HIDROXI, AMINO, CIANO, NITRO, OXO, ENTRE OTRAS CONDICIONES; Ar ES UN GRUPO a; Q ES UN GRUPO CARBOCICLICO, HETEROARILO; W ES H, O, CR7R8; R7 Y R8 SON H, ALQUILO C1-C6, O JUNTOS FORMAN UN GRUPO CICLICO DE 3-7 MIEMBROS; Z ES H, OH, ALCOXI C1-C6, CICLOALQUILO C3-C7, NR9COR10; R9 Y R10 SON H, ALQUILO C1-C6 O FORMAN JUNTOS CICLOALQUILO C3-C7; Z ES ARILO CARBOCICLICO, HETEROARILO, x E y SON 0-3; SON COMPUESTOS PREFERIDOS PIRIDIN-2-ILAMIDA DEL ACIDO 6-METIL-4-OXO-1,4,5,6,7,8-HEXAHIDRO-CICLOHEPTA[b]PIRROL-3-CARBOXILICO, ENTRE OTROS. LOS COMPUESTOS SE UNEN AL SITIO DE BENZODIAZEPINA DE LOS RECEPTORES GABA A Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE ANSIEDAD, DEPRESION, TRASTORNOS DEL SUENO, DEL LENGUAJE, ALZHEIMER
PE2002000597A 2001-07-06 2002-07-03 Derivados de acido cicloalquilpirrol-3-carboxilico y derivados de acido heterocicloalquilpirrol-3-carboxilico PE20030187A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30346701P 2001-07-06 2001-07-06

Publications (1)

Publication Number Publication Date
PE20030187A1 true PE20030187A1 (es) 2003-03-06

Family

ID=23172232

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000597A PE20030187A1 (es) 2001-07-06 2002-07-03 Derivados de acido cicloalquilpirrol-3-carboxilico y derivados de acido heterocicloalquilpirrol-3-carboxilico

Country Status (13)

Country Link
US (1) US6861529B2 (es)
EP (1) EP1404316A1 (es)
JP (1) JP2004538273A (es)
AP (1) AP2002002579A0 (es)
BR (1) BR0210821A (es)
CA (1) CA2452211A1 (es)
GT (1) GT200200140A (es)
HN (1) HN2002000164A (es)
MX (1) MXPA04000023A (es)
PA (1) PA8550001A1 (es)
PE (1) PE20030187A1 (es)
SV (1) SV2003001147A (es)
WO (1) WO2003004018A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04007606A (es) 2002-02-07 2004-11-10 Neurogen Corp Arilamidas de acido pirazolcarboxilico fusionadas substituidas y compuestos relacionados.
US7329288B2 (en) 2004-02-27 2008-02-12 L'oreal S.A. N-heteroaryl secondary para-phenylenediamine, a dye composition comprising such a para-phenylenediamine, a process for preparing this composition and use thereof
NZ551027A (en) 2004-04-08 2011-01-28 Targegen Inc Benzotriazine inhibitors of kinases
NZ592990A (en) 2005-11-01 2013-01-25 Targegen Inc Bi-aryl meta-pyrimidine inhibitors of kinases
US8293925B2 (en) * 2009-09-21 2012-10-23 Chemocentryx, Inc. Pyrrolidinone carboxamide derivatives
WO2012060847A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
US10953087B2 (en) 2016-05-30 2021-03-23 Janssen Vaccines & Prevention B.V. Stabilized pre-fusion RSV F proteins
CN114880926B (zh) * 2022-04-29 2025-01-28 杭州百子尖科技股份有限公司 一种基于格氏反应的数字孪生系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023265A (en) * 1990-06-01 1991-06-11 Schering Corporation Substituted 1-H-pyrrolopyridine-3-carboxamides
US5750702A (en) * 1993-10-27 1998-05-12 Neurogen Corporation Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands
US5484944A (en) * 1993-10-27 1996-01-16 Neurogen Corporation Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands
EP0888300A1 (en) 1996-03-22 1999-01-07 Neurogen Corporation Certain fused pyrrolecarboxamides as gaba brain receptor ligands
JP2003508385A (ja) 1999-08-31 2003-03-04 ニューロゲン コーポレイション 縮合ピロールカルボキサミド:gaba脳受容体リガンド

Also Published As

Publication number Publication date
WO2003004018A1 (en) 2003-01-16
MXPA04000023A (es) 2004-05-21
US6861529B2 (en) 2005-03-01
US20030069416A1 (en) 2003-04-10
AP2002002579A0 (en) 2002-09-30
GT200200140A (es) 2003-05-15
BR0210821A (pt) 2004-08-31
PA8550001A1 (es) 2003-11-12
SV2003001147A (es) 2003-03-18
CA2452211A1 (en) 2003-01-16
HN2002000164A (es) 2002-11-02
JP2004538273A (ja) 2004-12-24
EP1404316A1 (en) 2004-04-07

Similar Documents

Publication Publication Date Title
AR048523A1 (es) Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos
EP1437344A4 (en) BENZENE DERIVATIVES AND PROCESS FOR THE PREPARATION AND USE THEREOF
AR036659A1 (es) Compuestos derivados de fenil-piperazina, fenil-piperidina y fenil-tetrahidropiridina como inhibidores de la reabsorcion de la serotonina, una composicion farmaceutica y utilizacion de los mismos para la preparacion de medicamentos
CO4950625A1 (es) Derivados de nicotinamida
NO20053960L (no) Piperidin-benzensulfonamidderivater
AR039673A1 (es) Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metodos para su aplicacion
BRPI0510365A (pt) composto, método de produção de um composto, antagonista do receptor nk2, pró-droga, agente farmacêutico, métodos para antagonizar um recpetor nk2 e para evitar ou tratar doenças gastrintestinais funcionais, e, uso do composto ou uma pró-droga do mesmo
PE20001029A1 (es) Derivados de dihidrobenzodioxina carboxamida y acetona
PE20020720A1 (es) Derivados benzimidazol y piridilimidazol como ligandos para receptores gabaa
CO5590915A2 (es) Derivados de piperidina como antagonistas nk1 ( receptor del neuropeptido neuroquinina-1) con actividad antagonista superior en tratamientos de trastornos fisiologicos y disminucion de efectos colaterales
AR057987A1 (es) Compuestos agonistas de cb1 (receptor cannabinoide)
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
PE20030759A1 (es) Uso de ureas de benzotiazoles
PE20001467A1 (es) Derivados de 4-fenilpiridina como antagonistas del receptor de neuroquinina
PE20001551A1 (es) Derivados de eter biarilico como inhibidores de la recaptacion de monoaminas para el tratamiento de trastornos del snc
PE20030187A1 (es) Derivados de acido cicloalquilpirrol-3-carboxilico y derivados de acido heterocicloalquilpirrol-3-carboxilico
UY28578A1 (es) Derivados de amida
PE20020657A1 (es) Derivados de amida de piperidinas 1,4-disustituidas de formula (i)
PE20011084A1 (es) Derivados de quinolina como antagonistas alfa-2
AR044342A1 (es) Derivados de bencimidazol
UY23624A1 (es) Procedimiento para la preparacion de nuevos derivados de indol
PE20001543A1 (es) Derivados de piridopiranoacepinas, su preparacion y su aplicacion en terapeutica
AR029400A1 (es) Derivados de isoxazolcarboxamida, un metodo para su preparacion y una composicion farmaceutica que los comprende
ES2154605B1 (es) Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3
PE20221025A1 (es) Inhibidores de los receptores a2c adrenergicos

Legal Events

Date Code Title Description
FD Application declared void or lapsed